1015. A multicenter evaluation of antimicrobial utilization in hospitalized bone marrow transplant (BMT) and T-cell therapy (CAR-T) patients, and the impact on rates of C. difficile infection (CDI)

BACKGROUND: Benchmarking antimicrobial utilization through the National Healthcare Safety Network (NHSN) will be a CMS requirement in 2024. NHSN benchmarking is available for some hospitalized populations, but there are currently no benchmarking capabilities for BMT units. Additionally, there are no...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagel, Jerod, Boeser, Kimberly D, Hale, Cory, Harris, Alyssa, Jain, Rupali, Postelnick, Mike, Spivak, Emily S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678188/
http://dx.doi.org/10.1093/ofid/ofad500.046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678188/
http://dx.doi.org/10.1093/ofid/ofad500.046

Ejemplares similares